{"id":1078,"date":"2025-12-23T13:00:25","date_gmt":"2025-12-23T13:00:25","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/12\/23\/experimental-ms-therapy-reinforces-brakes-on-overactive-t-cells\/"},"modified":"2025-12-23T13:00:25","modified_gmt":"2025-12-23T13:00:25","slug":"experimental-ms-therapy-reinforces-brakes-on-overactive-t-cells","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2025\/12\/23\/experimental-ms-therapy-reinforces-brakes-on-overactive-t-cells\/","title":{"rendered":"Experimental MS therapy reinforces \u2018brakes\u2019 on overactive T-cells"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/12\/23\/higher-doses-ms-therapy-imp761-well-tolerated-dampen-immune-responses\/\" title=\"Experimental MS therapy reinforces \u2018brakes\u2019 on overactive T-cells\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2025\/05\/ThumbsUpRepeated-1-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A line of hands flashes a thumbs-up sign.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"149594\" \/><\/a><\/p>\n<p>Immutep\u2019s experimental immunotherapy, IMP761, continues to demonstrate a favorable safety profile, along with sustained suppression of T-cell activity, immune cells that are overly active in multiple sclerosis\u00a0(MS) and other autoimmune diseases. These findings are based on data from healthy people enrolled in an ongoing first-in-human Phase 1 trial (NCT06637865), who received single doses of IMP761 [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/12\/23\/higher-doses-ms-therapy-imp761-well-tolerated-dampen-immune-responses\/\">Experimental MS therapy reinforces \u2018brakes\u2019 on overactive T-cells<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2025\/12\/23\/higher-doses-ms-therapy-imp761-well-tolerated-dampen-immune-responses\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immutep\u2019s experimental immunotherapy, IMP761, continues to demonstrate a favorable safety profile, along with sustained suppression of T-cell activity, immune cells that are overly active in multiple sclerosis\u00a0(MS) and other autoimmune diseases. These findings are based on data from healthy people enrolled in an ongoing first-in-human Phase 1 trial (NCT06637865), who received single doses of IMP761&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1079,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1078","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1078"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1078\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1079"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}